Melt Extrusion
Contributor(s):: Haser, A, DiNunzio, JCMartin, C, McGinity, JW, Zhang, F
Techniques to overcome poor aqueous solubility of active pharmaceutical ingredients (APIs) continue to gain interest with a reported 30% of marketed compounds classified as BCS II and 10% classified as BCS IV. Approximately 70% of new chemical entities under development may be classified as BCS...